Risk of mortality (including sudden cardiac death) and major cardiovascular events in atypical and typical antipsychotic users: A study with the general practice research database

Cardiovascular Psychiatry and Neurology

Volumn 2013, Issue , 2013, Pages

  Murray Thomas, Tarita ^a   Jones, Meghan E ^b   Patel, Deven ^a   Brunner, Elizabeth ^b   Shatapathy, Chetan C ^b   Motsko, Stephen ^b   Van Staa, Tjeerd P ^a,c,d  

^a MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY   (United Kingdom)

^b ELI LILLY AND COMPANY   (United States)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; BENPERIDOL; CHLORPROMAZINE; CHLORPROTHIXENE; CLOZAPINE; DROPERIDOL; FLUPENTIXOL; FLUPHENAZINE; HALOPERIDOL; LEVOMEPROMAZINE; LOXAPINE; NEUROLEPTIC AGENT; OLANZAPINE; OXYPERTINE; PALIPERIDONE; PERICIAZINE; PERPHENAZINE; PIMOZIDE; PROMAZINE; QUETIAPINE; REMOXIPRIDE; RISPERIDONE; SERTINDOLE; SULPIRIDE; THIORIDAZINE; TRIFLUOPERAZINE; TRIFLUPERIDOL; ZOTEPINE;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; DEMENTIA; DRUG USE; FEMALE; GENERAL PRACTICE; HEART VENTRICLE ARRHYTHMIA; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MIDDLE AGED; MORTALITY; POPULATION; PRIORITY JOURNAL; SCHIZOPHRENIA; SUDDEN CARDIAC DEATH; VERY ELDERLY; YOUNG ADULT;

EID: 84896122530     PISSN: 20900163     EISSN: 20900171     Source Type: Journal    
DOI: 10.1155/2013/247486     Document Type: Article

References (53)

1. Ray W. A., Meredith S., Thapa P. B., Meador K. G., Hall K., Murray K. T., Antipsychotics and the risk of sudden cardiac death. Archives of General Psychiatry 2001 58 12 1161 1167 2-s2.0-0035199932 (Pubitemid 33121508)
2. Enger C., Weatherby L., Reynolds R. F., Glasser D. B., Walker A. M., Serious cardiovascular events and mortality among patients with schizophrenia. Journal of Nervous and Mental Disease 2004 192 1 19 27 2-s2.0-0346502779 10.1097/01.nmd.0000105996.62105.07 (Pubitemid 38101693)
3. Schneeweiss S., Setoguchi S., Brookhart A., Dormuth C., Wang P. S., Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients. CMAJ 2007 176 5 627 632 2-s2.0-33947264305 10.1503/cmaj.061250 (Pubitemid 46426056)
4. Ray W. A., Chung C. P., Murray K. T., Hall K., Stein C. M., Atypical antipsychotic drugs and the risk of sudden cardiac death. The New England Journal of Medicine 2009 360 3 225 235 2-s2.0-58349114259 10.1056/NEJMoa0806994
5. Haddad P. M., Sharma S. G., Adverse effects of atypical antipsychotics: differential risk and clinical implications. CNS Drugs 2007 21 11 911 936 2-s2.0-35048827065 (Pubitemid 47557106)
6. Kuller L., Lilienfeld A., Fisher R., An epidemiological study of sudden and unexpected deaths in adults. Medicine 1967 46 4 341 361 2-s2.0-0014108927
7. Manfredini R., Portaluppi F., Grandi E., Fersini C., Gallerani M., Out-of-hospital sudden death referring to an emergency department. Journal of Clinical Epidemiology 1996 49 8 865 868 2-s2.0-0030220081 10.1016/0895-4356(96) 00114-X (Pubitemid 26283397)
8. Albert C. M., Ma J., Rifai N., Stampfer M. J., Ridker P. M., Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation 2002 105 22 2595 2599 2-s2.0-0037024228 10.1161/01.CIR.0000017493.03108.1C (Pubitemid 34596034)
9. Priori S. G., Aliot E., Blomstrom-Lundqvist C., Bossaert L., Breithardt G., Brugada P., Camm A. J., Cappato R., Cobbe S. M., Di Mario C., Maron B. J., McKenna W. J., Pedersen A. K., Ravens U., Schwartz P. J., Trusz-Gluza M., Vardas P., Wellens H. J. J., Zipes D. P., Task force on sudden cardiac death of the european society of cardiology. European Heart Journal 2002 23 3 257 2-s2.0-0036488095 10.1053/euhj.2001.3134 (Pubitemid 36358250)
10. Schatzkin A., Cupples L. A., Heeren T., Sudden death in the Framingham heart study: differences in incidence and risk factors by sex and coronary disease status. American Journal of Epidemiology 1984 120 6 888 899 2-s2.0-0021752948 (Pubitemid 15216802)
11. Kannel W. B., Schatzkin A., Sudden death: lessons from subsets in population studies. Journal of the American College of Cardiology 1985 5 6 141B 149B 2-s2.0-0021888738 (Pubitemid 15063755)
12. Wannamethee G., Shaper A. G., Macfarlane P. W., Walker M., Risk factors for sudden cardiac death in middle-aged British men. Circulation 1995 91 6 1749 1756 2-s2.0-0028925676
13. Escobedo L. G., Zack M. M., Comparison of sudden and nonsudden coronary deaths in the United States. Circulation 1996 93 11 2033 2036 2-s2.0-0030013031 (Pubitemid 26165567)
14. Osborn D. P. J., Levy G., Nazareth I., Petersen I., Islam A., King M. B., Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Research Database. Archives of General Psychiatry 2007 64 2 242 249 2-s2.0-33846882362 10.1001/archpsyc.64.2.242 (Pubitemid 46220782)
15. Dixon L., Postrado L., Delahanty J., Fischer P. J., Lehman A., The association of medical comorbidity in schizophrenia with poor physical and mental health. Journal of Nervous and Mental Disease 1999 187 8 496 502 2-s2.0-0032830457 10.1097/00005053-199908000-00006 (Pubitemid 29422604)
16. Curkendall S. M., Mo J., Glasser D. B., Stang M. R., Jones J. K., Cardiovascular disease in patients with schizophrenia in Saskatchewan, Canada. Journal of Clinical Psychiatry 2004 65 5 715 720 2-s2.0-2942726250 10.4088/JCP.v65n0519
17. Williams T., van Staa T. P., Puri S., Eaton S., Recent advances in the utility and use of the General Practice Research Database as an example of a UK Primary Care Data resource. Therapeutic Advances in Drug Safety 2012 3 89 99 10.1177/2042098611435911
18. Herrett E., Thomas S. L., Schoonen W. M., Smeeth L., Hall A. J., Validation and validity of diagnoses in the General Practice Research Database: a systematic review. British Journal of Clinical Pharmacology 2010 69 1 4 14 2-s2.0-72949102852 10.1111/j.1365-2125.2009.03537.x
19. Hennessy S., Leonard C. E., Freeman C. P., Deo R., Newcomb C., Kimmel S. E., Strom B. L., Bilker W. B., Validation of diagnostic codes for outpatient-originating sudden cardiac death and ventricular arrhythmia in Medicaid and Medicare claims data. Pharmacoepidemiology and Drug Safety 2010 19 6 555 562 2-s2.0-77953500016 10.1002/pds.1869
20. Gardner D. M., Murphy A. L., O'Donnell H., Centorrino F., Baldessarini R. J., International consensus study of antipsychotic dosing. American Journal of Psychiatry 2010 167 6 686 693 2-s2.0-77952974468 10.1176/appi.ajp.2009.09060802
21. Hosmer D. W., Lemeshow S., Applied Logistic Regression 2000 2nd New York, NY, USA John Wiley and Sons
22. Vittinghoff E., McCulloch C. E., Relaxing the rule of ten events per variable in logistic and cox regression. American Journal of Epidemiology 2007 165 6 710 718 2-s2.0-33847382959 10.1093/aje/kwk052 (Pubitemid 46348374)
23. Ramlau-Hansen H., Smoothing counting process intensities by means of kernel functional. Annals of Statistics 1983 11 2 453 466 10.1214/aos/1176346152
24. Høyer E. H., Mortensen P. B., Olesen A. V., Mortality and causes of death in a total national sample of patients with affective disorders admitted for the first time between 1973 and 1993. British Journal of Psychiatry 2000 176 76 82 2-s2.0-0033966198 10.1192/bjp.176.1.76 (Pubitemid 30051094)
25. Stroup T. S., Lieberman J. A., McEvoy J. P., Swartz M. S., Davis S. M., Capuano G. A., Rosenheck R. A., Keefe R. S. E., Miller A. L., Belz I., Hsiao J. K., Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study. American Journal of Psychiatry 2007 164 3 415 427 2-s2.0-34047139907 10.1176/appi.ajp. 164.3.415 (Pubitemid 46513155)
26. Schneider L. S., Dagerman K. S., Insel P., Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. Journal of the American Medical Association 2005 294 15 1934 1943 2-s2.0-26844538114 10.1001/jama.294.15.1934 (Pubitemid 41464695)
27. Gill S. S., Bronskill S. E., Normand S.-L. T., Anderson G. M., Sykora K., Lam K., Bell C. M., Lee P. E., Fischer H. D., Herrmann N., Gurwitz J. H., Rochon P. A., Antipsychotic drug use and mortality in older adults with dementia. Annals of Internal Medicine 2007 146 11 775 786 2-s2.0-34250631300 (Pubitemid 351650498)
28. Schneeweiss S., Setoguchi S., Brookhart A., Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients. CMAJ 2007 176 11 1613 2-s2.0-34249909750 10.1503/cmaj.070582 (Pubitemid 46868615)
29. Setoguchi S., Wang P. S., Alan Brookhart M., Canning C. F., Kaci L., Schneeweiss S., Potential causes of higher mortality in elderly users of conventional and atypical antipsychotic medications. Journal of the American Geriatrics Society 2008 56 9 1644 1650 2-s2.0-51249092361 10.1111/j.1532-5415. 2008.01839.x
30. Huybrechts K. F., Gerhard T., Crystal S., Olfson M., Avorn J., Levin R., Lucas J. A., Schneeweiss S., Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: Population based cohort study. BMJ 2012 344 7848, article e977 2-s2.0-84858419468 10.1136/bmj.e977
31. Wang P. S., Schneeweiss S., Avorn J., Fischer M. A., Mogun H., Solomon D. H., Brookhart M. A., Risk of death in elderly users of conventional vs. atypical antipsychotic medications. The New England Journal of Medicine 2005 353 22 2335 2341 2-s2.0-28244431743 10.1056/NEJMoa052827 (Pubitemid 41713745)
32. Trifirò G., Verhamme K. M. C., Ziere G., Caputi A. P., Stricker B. H. C., Sturkenboom M. C. J. M., All-cause mortality associated with atypical and typical antipsychotics in demented outpatients. Pharmacoepidemiology and Drug Safety 2007 16 5 538 544 2-s2.0-34249660551 10.1002/pds.1334 (Pubitemid 46824275)
33. Bralet M.-C., Yon V., Loas G., Noisette C., Mortality in schizophrenia: a 8-year follow-up study in 150 chronic schizophrenics. Encephale 2000 26 6 32 41 2-s2.0-17644431499 (Pubitemid 32101438)
34. Hansen V., Arnesen E., Jacobsen B. K., Total mortality in people admitted to a psychiatric hospital. British Journal of Psychiatry 1997 170 186 190 2-s2.0-0030946355 (Pubitemid 27120657)
35. Black D. W., Iowa record-linkage study: death rates in psychiatric patients. Journal of Affective Disorders 1998 50 2-3 277 282 2-s2.0-0032170841 10.1016/S0165-0327(98)00019-6 (Pubitemid 28551797)
36. Baxter D. N., The mortality experience of individuals on the Salford Case Register: I. all-cause mortality. British Journal of Psychiatry 1996 168 772 779 2-s2.0-0030014564
37. Corten P., Ribourdouille M., Dramaix M., Premature death among outpatients at a community mental health center. Hospital and Community Psychiatry 1991 42 12 1248 1251 2-s2.0-0026346134
38. Idler E. L., Age differences in self-assessments of health: age changes, cohort differences, or survivorship? Journals of Gerontology 1993 48 6 S289 S300 2-s2.0-0027365362 (Pubitemid 23333646)
39. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinology, North American Association for the Study of Obesity, Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 2004 27 2 596 601 2-s2.0-0842348094 10.2337/diacare.27.2.596 (Pubitemid 38180442)
40. Langan J., Shajahan P., Antipsychotic polypharmacy: review of mechanisms, mortality and management. Psychiatrist 2010 34 2 58 62 2-s2.0-77951152707 10.1192/pb.bp.108.024257
41. Ilyas S., Moncrieff J., Trends in prescriptions and costs of drugs for mental disorders in England, 1998-2010. British Journal of Psychiatry 2012 200 5 393 398 2-s2.0-84860551922 10.1192/bjp.bp.111.104257
42. National Institute for Clinical Excellence, 2002, Guidance on the use of newer (atypical) antipsychotic agents for the treatment of schizophrenia- [TA43 ]
43. King D., Knapp M., Patterns of, and factors associated with, atypical and typical antipsychotic prescribing by general practitioners in the UK during the 1990s. Journal of Mental Health 2006 15 3 269 278 2-s2.0-33745698748 10.1080/09638230600714293 (Pubitemid 43995542)
44. Hennessy S., Leonard C. E., Palumbo C. M., Bilker W. B., Newcomb C., Kimmel S. E., Diagnostic codes for sudden cardiac death and ventricular arrhythmia functioned poorly to identify outpatient events in EPIC's General Practice Research Database. Pharmacoepidemiology and Drug Safety 2008 17 12 1131 1136 2-s2.0-59649084983 10.1002/pds.1632
45. Hoffman B. F., Dangman K. H., The role of antiarrhythmic drugs in sudden cardiac death. Journal of the American College of Cardiology 1986 8 1 104A 109A 2-s2.0-0022475866 (Pubitemid 16064085)
46. Doig J. C., Drug-induced cardiac arrhythmias. Incidence, prevention and management. Drug Safety 1997 17 4 265 275 2-s2.0-9844251769
47. Vieweg W. V. R., Wood M. A., Tricyclic antidepressants, QT interval prolongation, and torsade de pointes. Psychosomatics 2004 45 5 371 377 2-s2.0-4444345419 10.1176/appi.psy.45.5.371 (Pubitemid 39166908)
48. Bingefors K., Isacson D., Von Knorring L., Smedby B., Wicknertz K., Antidepressant-treated patients in ambulatory care mortality during a nine-year period after first treatment. British Journal of Psychiatry 1996 169 5 647 654 2-s2.0-0029804605
49. Ryan J., Carriere I., Ritchie K., Stewart R., Toulemonde G., Dartigues J.-F., Tzourio C., Ancelin M.-L., Late-life depression and mortality: influence of gender and antidepressant use. British Journal of Psychiatry 2008 192 1 12 18 2-s2.0-38749128788 10.1192/bjp.bp.107.039164 (Pubitemid 351183155)
50. Whang W., Kubzansky L. D., Kawachi I., Rexrode K. M., Kroenke C. H., Glynn R. J., Garan H., Albert C. M., Depression and risk of sudden cardiac death and coronary heart disease in women. Results from the Nurses' Health Study. Journal of the American College of Cardiology 2009 53 11 950 958 2-s2.0-61549142787 10.1016/j.jacc.2008.10.060
51. Ray W. A., Murray K. T., Meredith S., Narasimhulu S. S., Hall K., Stein C. M., Oral erythromycin and the risk of sudden death from cardiac causes. The New England Journal of Medicine 2004 351 11 1089 1159 2-s2.0-19244365446 10.1056/NEJMoa040582 (Pubitemid 39167513)
52. Staffa J. A., Jones J. K., Gable C. B., Verspeelt J. P., Amery W. K., Risk of selected serious cardiac events among new users of antihistamines. Clinical Therapeutics 1995 17 6 1062 1077 2-s2.0-0029608998 10.1016/0149- 2918(95)80085-9 (Pubitemid 26035660)
53. De Abajo F. J., Rodríguez L. A., Risk of ventricular arrhythmias associated with nonsedating antihistamine drugs. British Journal of Clinical Pharmacology 1999 47 3 307 313 2-s2.0-0033061972 10.1046/j.1365-2125.1999.00885. x (Pubitemid 29131346)